buserelin has been researched along with Testicular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordeschi, G; Francavilla, S; Galassi, P; Miano, L; Paradiso Galatioto, G; Properzi, G; Vicentini, C | 1 |
| Huben, RP; Klioze, SS; Nseyo, UO; Pontes, JE | 1 |
2 other study(ies) available for buserelin and Testicular Diseases
| Article | Year |
|---|---|
Testicular changes after treatment with a GnRH analog (buserelin) in association with cyproterone acetate in men with prostatic cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Humans; Leydig Cells; Male; Middle Aged; Prostatic Neoplasms; Sertoli Cells; Spermatogenesis; Testicular Diseases; Testosterone | 1989 |
Protection of germinal epithelium with luteinizing hormone-releasing hormone analogue.
Topics: Animals; Antineoplastic Agents; Buserelin; Cisplatin; Cyclophosphamide; Dogs; Hypothalamo-Hypophyseal System; Male; Radiation-Protective Agents; Radiotherapy; Testicular Diseases; Testis | 1985 |